Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-1-24
|
pubmed:abstractText |
Recent studies have shown that the risk conferred by the high-risk DQA1*03-DQB1*0302 (DQ8) haplotype is modified by the DRB1*04 allele that is also carried by this haplotype. However, many of these studies suffer from lack of sufficient numbers of DQ-matched control subjects, which are necessary because there is a strong linkage disequilibrium between genes in the HLA complex. In the present study, using a large material of IDDM patients and DQ-matched control subjects, we have addressed the contribution of DR4 subtypes to IDDM susceptibility. Our data, together with recent data from others, clearly demonstrate that some DR4-DQ8 haplotypes are associated with disease susceptibility, while others are associated with protection, depending on the DRB1*04 allele carried by the same haplotype. In particular, our data demonstrate that DRB1*0401 confers a higher risk than DRB1*0404. Based on combined available data on the genetic susceptibility encoded by various DR4-DQ8 haplotypes and the amino acid composition of the involved DRbeta*04 chains as well as the ligand motifs for these DR4 subtypes, we have developed a unifying hypothesis explaining the different risks associated with different DR4-DQ8 haplotypes. We suggest that disease susceptibility is mainly conferred by DQ8 while DR4 subtypes confer different degrees of protection. Some DR4 subtypes (i.e., DRB1*0405, 0402, and 0401) confer little or no protection, while others (i.e., DRB1*0404, 0403, and 0406) cause an increasing degree of protection, possibly by binding a common protective peptide. Features of a protective peptide that fit such a model are briefly discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ alpha-Chains,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQA1 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR4 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DRB1*04:01 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DRB1 Chains
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0012-1797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
143-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8971095-Adolescent,
pubmed-meshheading:8971095-Child,
pubmed-meshheading:8971095-Diabetes Mellitus, Type 1,
pubmed-meshheading:8971095-Disease Susceptibility,
pubmed-meshheading:8971095-Genotype,
pubmed-meshheading:8971095-HLA-DQ Antigens,
pubmed-meshheading:8971095-HLA-DQ alpha-Chains,
pubmed-meshheading:8971095-HLA-DR Antigens,
pubmed-meshheading:8971095-HLA-DR4 Antigen,
pubmed-meshheading:8971095-HLA-DRB1 Chains,
pubmed-meshheading:8971095-Haplotypes,
pubmed-meshheading:8971095-Humans,
pubmed-meshheading:8971095-Reference Values,
pubmed-meshheading:8971095-Risk Assessment,
pubmed-meshheading:8971095-Risk Factors
|
pubmed:year |
1997
|
pubmed:articleTitle |
HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.
|
pubmed:affiliation |
Institute of Transplantation Immunology, The National Hospital, Oslo, Norway. d.e.undlien@rh.uio.no
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|